Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenxiang Yangwei
- Development stage
- Unknown
- Lead developer
- Guangdong Zhongda Nanhai Marine Biotechnology Engineering
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shenxiang Yangwei is a Traditional Chinese Medicine (TCM) formulation developed by the Guangdong Zhongda Nanhai Marine Biotechnology Engineering Center Co., Ltd. It is primarily indicated for the treatment of peptic ulcers and chronic gastritis. The drug is formulated to provide gastroprotective effects by enhancing the gastric mucosal barrier, inhibiting the secretion of gastric acid and pepsin, and reducing the levels of pro-inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-6 (IL-6). It typically contains natural ingredients like *Panax ginseng* and *Aquilaria sinensis*, which work synergistically to alleviate symptoms such as epigastric pain, bloating, and acid regurgitation. The developer's expertise in marine biotechnology suggests the potential inclusion of marine-derived bioactive compounds aimed at improving the therapeutic profile of the traditional herbal base.
- Brand names
- Shenxiang Yangwei
- Other names
- Shenxiang Yangwei JiaonangShenxiang Yangwei Granules参香养胃胶囊参香养胃颗粒
02
Targets
CCK2R (Cholecystokinin 2 Receptor)PEP (Pepsin)PTGER (Prostaglandin E2 receptor)
Beyond the preview
Go deeper on Shenxiang Yangwei.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenxiang Yangwei.